Cholangiocarcinoma: a review of the literature and future directions in therapy

por Halder, Ritika, Amaraneni, Akshay, Shroff, Rachna T.
Publicado 2022

Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015

por Koshiol, Jill, Yu, Binbing, Kabadi, Shaum M., Baria, Katherine, Shroff, Rachna T.
Publicado 2022

Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers

por Mizrahi, Jonathan D, Gunchick, Valerie, Mody, Kabir, Xiao, Lianchun, Surapaneni, Phanikeerthi, Shroff, Rachna T, Sahai, Vaibhav
Publicado 2020

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater

por Gulhati, Pat, Raghav, Kanwal, Shroff, Rachna, Varadhachary, Gauri, Javle, Milind, Qiao, Wei, Wang, Huamin, Morris, Jeffrey, Wolff, Robert, Overman, Michael J.
Publicado 2017

Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism

por Recio-Boiles, Alejandro, Veeravelli, Sumana, Vondrak, Jessica, Babiker, Hani M, Scott, Aaron J, Shroff, Rachna T, Patel, Hitendra, Elquza, Emad, McBride, Ali
Publicado 2019

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

por Abdel-Wahab, Reham, Varadhachary, Gauri R., Bhosale, Priya R., Wang, Xuemei, Fogelman, David R., Shroff, Rachna T., Overman, Michael J., Wolff, Robert A., Javle, Milind
Publicado 2018

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

por Javle, Milind M, Shroff, Rachna T, Xiong, Henry, Varadhachary, Gauri A, Fogelman, David, Reddy, Shrikanth A, Davis, Darren, Zhang, Yujian, Wolff, Robert A, Abbruzzese, James L
Publicado 2010

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

por Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Publicado 2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

por Shroff, Rachna T, Yarchoan, Mark, O'Connor, Ashley, Gallagher, Denise, Zahurak, Marianna L, Rosner, Gary, Ohaji, Chimela, Sartorius-Mergenthaler, Susan, Parkinson, Rose, Subbiah, Vivek, Zinner, Ralph, Azad, Nilofer S
Publicado 2018

Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease

por Vrba, Lukas, Futscher, Bernard W., Oshiro, Marc, Watts, George S., Menashi, Emmanuel, Hu, Charles, Hammad, Hytham, Pennington, Daniel R., Golconda, Umamaheshwari, Gavini, Hemanth, Roe, Denise J., Shroff, Rachna T., Nelson, Mark A.
Publicado 2022

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

por Fogelman, David R., Holmes, Holly, Mohammed, Khalil, Katz, Matthew H. G., Prado, Carla M., Lieffers, Jessica, Garg, Naveen, Varadhachary, Gauri R., Shroff, Rachna, Overman, Michael J., Garrett, Christopher, Wolff, Robert A., Javle, Milind
Publicado 2014

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma

por Rogers, Jane E., Mizrahi, Jonathan D., Xiao, Lianchun, Mohindroo, Chirayu, Shroff, Rachna T., Wolff, Robert, Varadhachary, Gauri R., Javle, Milind M., Overman, Michael, Fogelman, David R., Raghav, Kanwal P. S., Pant, Shubham, McAllister, Florencia
Publicado 2020

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures

por Mody, Kabir, Jain, Prerna, El-Refai, Sherif M., Azad, Nilofer S., Zabransky, Daniel J., Baretti, Marina, Shroff, Rachna T., Kelley, R. Katie, El-Khouiery, Anthony B., Hockenberry, Adam J., Lau, Denise, Lesinski, Gregory B., Yarchoan, Mark
Publicado 2022

Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling

por Javle, Milind, Rashid, Asif, Churi, Chaitanya, Kar, Siddhartha, Zuo, Mingxin, Eterovic, Agda Karina, Nogueras-Gonzalez, Graciela M., Ali, Siraj, Janku, Filip, Shroff, Rachna, Aloia, Thomas A, Vauthey, Jean-Nicholas, Curley, Steven, Mills, Gordon, Roa, Ivan
Publicado 2013

HER2/neu-directed therapy for biliary tract cancer

por Javle, Milind, Churi, Chaitanya, Kang, HyunSeon C., Shroff, Rachna, Janku, Filip, Surapaneni, Rakesh, Zuo, Mingxin, Barrera, Christian, Alshamsi, Humaid, Krishnan, Sunil, Mishra, Lopa, Wolff, Robert A., Kaseb, Ahmed O., Thomas, Melanie B., Siegel, Abby B.
Publicado 2015

Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma

por Holokai, Loryn, Chakrabarti, Jayati, Lundy, Joanne, Croagh, Daniel, Adhikary, Pritha, Richards, Scott S., Woodson, Chantal, Steele, Nina, Kuester, Robert, Scott, Aaron, Khreiss, Mohammad, Frankel, Timothy, Merchant, Juanita, Jenkins, Brendan J., Wang, Jiang, Shroff, Rachna T., Ahmad, Syed A., Zavros, Yana
Publicado 2020

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

por Churi, Chaitanya R., Shroff, Rachna, Wang, Ying, Rashid, Asif, Kang, HyunSeon C., Weatherly, Jacqueline, Zuo, Mingxin, Zinner, Ralph, Hong, David, Meric-Bernstam, Funda, Janku, Filip, Crane, Christopher H., Mishra, Lopa, Vauthey, Jean-Nicholas, Wolff, Robert A., Mills, Gordon, Javle, Milind
Publicado 2014

What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature

por McNamara, Mairéad G, Bridgewater, John, Goyal, Lipika, Jacobs, Timothy, Wagner, Anna D, Goldstein, David, Shroff, Rachna, Moehler, Markus, Lowery, Maeve, Bekaii-Saab, Tanios, Kelley, Robin K, Furuse, Junji, Rimassa, Lorenza, Morizane, Chigusa, Lamarca, Angela, Hubner, Richard, Knox, Jennifer, Valle, Juan
Publicado 2022

Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin

por Overman, Michael J., Morris, Van, Moinova, Helen, Manyam, Ganiraju, Ensor, Joe, Lee, Michael S., Eng, Cathy, Kee, Bryan, Fogelman, David, Shroff, Rachna T., LaFramboise, Thomas, Mazard, Thibault, Feng, Tian, Hamilton, Stanley, Broom, Bradley, Lutterbaugh, James, Issa, Jean-Pierre, Markowitz, Sanford D., Kopetz, Scott
Publicado 2016

Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer

por Ogobuiro, Ifeanyichukwu, Baca, Yasmine, Ribeiro, Jennifer R., Walker, Phillip, Wilson, Gregory C., Gulhati, Prateek, Marshall, John L., Shroff, Rachna T., Spetzler, David, Oberley, Matthew J., Abbott, Daniel E., Kim, Hong Jin, Kooby, David A., Maithel, Shishir K., Ahmad, Syed A., Merchant, Nipun B., Xiu, Joanne, Hosein, Peter J., Datta, Jashodeep
Publicado 2023